The University of Maryland BioPark announced today that Fluxome Inc., a nutraceutical ingredient company using novel metabolic engineering and fermentation methods, is the newest company to join the growing community of commercial tenants at the BioPark. According to Fluxome’s lease with building owner Wexford Science & Technology, LLC, Fluxome has based its U.S. headquarters and commercial operations in the BioPark building at 801 West Baltimore Street in Baltimore.
Said Jane Shaab, University of Maryland Research Park Corporation Senior Vice President, “It’s exciting to have another international tenant join us and it is especially rewarding to welcome Fluxome’s President and CEO Angela Tsetsis, who was previously on the management team at Columbia-based Martek (now Royal DSM N.V.), back to Maryland’s business community. Under Angela’s leadership, Fluxome is an example of a next-generation Maryland life sciences company.”
Fluxome, which was established in 2002 as a spinoff from the Technical University of Denmark (DTU), is the producer of pure and natural Fluxome® resveratrol. A science-based technology company, Fluxome’s mission is to develop high-value ingredients that promote health and wellness from environmentally renewable sources.
“The BioPark and Baltimore immediately felt like a ‘home’ for Fluxome with the people, dynamics, and resources available in a convenient central location that support the development of establishing a presence in the United States,” said Ms. Tsetsis, Fluxome President and Chief Executive Officer. “We are proud to be a part of the BioPark community and look forward to participating in the collaboration amongst the tenants and the University to further the interaction between academia and industry.”
About Fluxome® Resveratrol
Resveratrol is a natural polyphenol compound that is produced by several types of plants as a protective response against environmental stress factors. Resveratrol is a potent antioxidant, also found in red wine, and by many considered the key to the “French Paradox” – the low incidence of heart disease in France despite a high-fat diet. For decades resveratrol has been studied by scientists around the globe, generating a large and growing body of scientific evidence that highlights the protective benefits of resveratrol against health conditions related to aging.
Fluxome® Resveratrol is natural and 98% pure form of trans-resveratrol from a safe renewable source. It is contaminant-free, allergen-free and easily incorporated into dietary supplements, nutritious foods, beverages, and cosmetics, without noticeably affecting taste, color or odor. Fluxome® Resveratrol is U.S. GRAS affirmed, European Novel Foods approved and Kosher certified. For more information and/or product enquiries please send an email to This email address is being protected from spambots. You need JavaScript enabled to view it..
About the University of Maryland BioPark
The UM BioPark is a biomedical research park on the campus of the University of Maryland, Baltimore. The BioPark welcomes additional life science companies to join its growing scientific community of emerging, high-growth life science tenants and University of Maryland (UM) translational research and clinical treatment centers. For early-stage to mature bioscience companies, the BioPark offers a sophisticated laboratory and office environment on the UM’s vibrant academic medical center campus. Community members are commercializing new drugs, diagnostics and devices and advancing biomedical research. Learn more about BioPark tenants at http://www.umbiopark.com/tenants.aspx.